Expo Hub
Cancer Care Day
Shaping the Future of Cancer Care
Shaping the Future of Cancer Care
The future of cancer care is shaped by technological innovation and a strong patient focus. The goal of Siemens Healthineers is to transform Cancer Care and create a world without fear of cancer together with our customers. With more than 800 participants, Cancer Care Day at ECR 2025 was a great success, addressing the topic Shaping the Future of Cancer Care. The opening panel discussion focused on new advancements and future-shaping trends in Cancer Care, followed by four scientific symposia and panel discussions on breast, prostate, liver and lung cancer.
Watch the recordings from Cancer Care Day 2025
Shaping the future of Cancer Care: Opening Panel Discussion
1 / 0
Kick-off Presentations
In this first half of the session, the four panelists give introductory talks on their subjects of expertise ahead of the panel discussion in part two.
Panel discussion
In this panel discussion, experts highlight the increasing importance of integrating diagnostics, personalized therapy, and artificial intelligence along the entire continuum of care.
Breast Cancer Symposium
1 / 0
Rethinking Breast Cancer Follow-up: Exploring Contrast-Enhanced Mammography as a Game-Changer
Assess Current Follow-Up Practices: Gain insights into the existing imaging methods for breast cancer follow-up, understanding their strengths and limitations in post-surgical patients.Introduce CEM as an AlternativeEnvision the Future of Follow-Up
DBT in women with average risk
To know the literature evidence to use DBT for breast screening and to understand the main limitations that explain the absence of implementation in many countries. Also to explore the next future with AI implementation
The clinical utility of super high frequency ultrasound probes in breast examinations – benefits and limitations
The diagnosis and monitoring of breast pathologies have been significantly improved by the availability of very high frequency probes in breast ultrasound.
Optimizing MRI for breast cancer screening
Ritse Mann examines the evolving role of breast MRI in clinical practice, with a particular focus on its potential in breast cancer screening.
Prostate Cancer Symposium
1 / 0
Prostate imaging and image quality: the impact of the PI-QUAL score on our approach to prostate MRI
High-quality MRI images are essential for any diagnostic pathway for prostate cancer, as they play a critical role in ensuring accurate detection and guiding subsequent management decisions.
Prostate MRI applications in the era of Deep learning reconstruction: Challenges and Opportunities
In recent years, advancements in deep learning image reconstruction have transformed the way prostate MRI is performed by significantly reducing scan times and enhancing image quality.
Advancing Prostate MRI Reading and Interpretation with AI: Improving Accuracy and Efficiency in Clinical Practice
AI-driven advancements in prostate MRI reading, including automatic lesion detection and classification, offer promising solutions to streamline diagnostics and enhance accuracy in identifying clinically significant prostate cancer.
Lung Cancer Symposium
1 / 0
Illuminating Lung Cancer: The Power of Nuclear Medicine in Early Diagnosis and Guiding Treatment Decisions
Dr. Grawe delivered an insightful talk titled "Illuminating Lung Cancer: The Power of Nuclear Medicine in Early Diagnosis and Guiding Treatment Decisions".
Together Moving Ahead: Principles and Development of Direct i4D
Co-creator René Werner explained the concept behind Direct i4D, shows how it works, and shared results from peers.
Image Guidance and Robotics: Indispensable Tools for the Next Level in Thoracic Surgery
This talk highlights the impact of early detection and screening on surgical strategies, innovative approaches like the cross-talk between ION and Cios Spin, and the role of single anesthetic events as a patient-centered pathway. Emphasis is placed on a multidisciplinary setup to advance lung cancer care.
Liver Cancer Symposium
1 / 0
The role of liver MRI in interventional radiology
Professor Max Seidensticker concludes the symposium with an innovative session on MRI-Guided Interventions.
New guidelines for new treatments in MASLD/MASH: how to diagnose and stage your patient
As metabolic-associated liver disease presents unique challenges in clinical management and is one of the main precursors of liver cancer, Professor Thomas Reiberger reviews updated guidelines on diagnosing and staging MASLD/MASH and explores critical tools and techniques for non-invasive assessments and advanced imaging markers.
Revolutionizing HCC diagnosis and staging: MRI protocol optimization meets AI
Dr. Saif Afat talks about the role of Artificial Intelligence (AI) on protocol optimization in improving Hepatocellular Carcinoma (HCC) lesion detection using MRI and staging using contrast-enhanced MRI.
Watch the recordings from Cancer Care Day 2024
1 / 0
How established does an examination method need to be before it is integrated in breast cancer screening programs?
In this symposium, experts will discuss when and how European guidelines will be updated to reflect new clinical experience, scientific evidence, and technological developments.
Interdisciplinary perspectives in Lung Cancer: advancements in screening modalities and surgical implications
Dive into the forefront of lung cancer management at our symposium, where we explore cutting-edge screening techniques and their direct impact on surgical strategies.
Success factors and hurdles in setting up screening programs
In this panel discussion, experts will provide an overview of the current status of these three screening programs, their success factors and hurdles, and their respective use of AI.
The right patient, at the right time: How to optimize outcomes for HCC patients with liver imaging?
Healthcare providers seek ways to better stratify patients with liver diseases to detect HCC earlier and ultimately improve outcomes.
Meeting clinical needs in prostate cancer with MRI, next-generation imaging and theranostics
In this symposium, experts from different disciplines will navigate the impact of imaging at various states of the prostate cancer patient journey, offering valuable insights and clinical cases examples.
Related links
Partner Bayer
